A randomized controlled clinical study of lower-dose peginterferon alfa-2b in combination with ribav

• 作 者: 罗端德
• 机 构: Dept Infect Dis Union Hosp Tongji Med Coll,Huazhong Sci & Technol Univ,Wuhan 430022,
• 出 处: China Medical Abstracts(Internal Medicine)
• 发表日期: 2006年04期
• 关键词: ribavirin interferon fellow versus sustained assigned stand feron

Objective To compare the efficacy and safety of lower-dose peginterferon alfa-2b plus ribavirin versus standard interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in China. Methods 192 patients with chronic hepatitis C were assigned peginterferon alfa-2b 0.5μg/kg each week plus ribavirin 750～1050 mg/d or standard interferon alfa-2b 3 MIU TIW plus ribavirin 750～1050 mg/d for 48-week treatment and 24-week fellow

Objective To compare the efficacy and safety of lower-dose peginterferon alfa-2b plus ribavirin versus standard interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in China. Methods 192 patients with chronic hepatitis C were assigned peginterferon alfa-2b 0.5 μg / kg each week plus ribavirin 750 ~ 1050 mg / d or standard interferon alfa-2b 3 MIU TIW plus ribavirin 750 ~ 1050 mg / d for 48-week treatment and 24-week fellow